We are monitoring the impact of COVID-19 on Influenza Diagnostics Market Get in touch with us for detailed analysis Know More
Pulished Date April, 2021
ID: 11410
Share on
Share on

Global Influenza Diagnostics Market Size, Share, Trends, Growth, COVID-19 Impact Analysis Report – Segmented By Test Type, Type of Flu, End-User and Region (North America, Europe, Asia-Pacific, Latin America, Middle East and Africa) – Industry Forecast (2021 to 2026)

Pulished: April, 2021
ID: 11410
Pages: 190

Global Influenza Diagnostics Market Size (2021 to 2026)

As per our analysis report, the global influenza diagnostics market size is predicted to worth USD 1.12 billion by the end of 2026, growing at a CAGR of 6.32% during the forecast period.

Appropriate collection, storage, and respiratory sample transportation is the fundamental first step in influenza infection disease detection. Influenza diagnostics is done by various clinical evaluation methods, sometimes by rapid diagnostic testing or molecular testing. The diagnostic tests include rapid molecular assays, reverse transcription-polymerase chain reaction (RT-PCR), rapid influenza diagnostic tests and immunofluorescence assays, and other nucleic acid amplification tests.  Furthermore, there are many point-of-care tests available for influenza. Pulse oximetry and chest x-ray are used in the case of patients with severe respiratory symptoms.

MARKET DRIVERS:

Y-O-Y growth in the prevalence of influenza and growing support from the governments drive the global influenza diagnostics market growth.

According to the WHO, about 20% of children and 10% of adults are infected with the influenza virus every year globally. Although a patient will recover from influenza without medication in 2-3 weeks, it is essential to detect it. However, it can get difficult, resulting in pneumonia, Bronchitis, Heart Attacks, and Acute Respiratory Distress Syndrome.

The increasing prevalence of influenza and diseases associated with it is a major factor responsible for the growth of the influenza diagnostic market. According to CDC, in the United States, around 35.5 million people were ill with influenza, 16.5 million visited a doctor for their illness, 490,600 were hospitalized, and 34,200 died due to the flu in 2018 - 2019. In 2019–2020, there are 38 million people harmed by influenza, 18 million visits to a primary care provider for influenza, 400,000 hospitalizations for influenza, and 22,000 influenza deaths. This disease burden has varied for the last 70 years in the various forms of the diseases. Hence there are numerous tests carried out to diminish this burden. As a result, it helps in the growth of the influenza diagnostics market.

The government's focus to prevent and monitor influenza is one of the factors contributing to the growth of the global influenza diagnostics industry. Many counties focus on preventing influenza throughout the years, like in India, after the avian influenza pandemic government started a five-step plan to diagnose and prevent influenza. WHO’s “The Global Influenza Programme” (GIP) helps the Member States with critical guidance, specialized assistance, and preparation of exercises required to strengthen their wellbeing mechanisms arranged against sporadic, zoonotic, and pandemic influenza dangers. Also, the government provides funding to various firms for influenza diagnostic testing, such as Diassess Inc., a next-generation infectious disease testing company, which receives $21.9M government funding in 2018 to advance the development of its flu diagnostic technology. These efforts eventually lead to increases in the growth of the influenza diagnostics market.

Growing awareness regarding early diagnosis of influenza also responsible for the growth of the influenza diagnostics market. An early diagnosis of influenza aids the doctor in deciding on care and assistance. It also aids in the prevention of more complications caused by influenza-related diseases. These early detections also raise further diagnostic tests based on the results. Henceforth, this awareness in the population for early diagnosis of influenza leads to the growth of the global influenza diagnostics market.

MARKET RESTRAINTS:

Nonetheless, the stringent FDA regulations, variability in specificity and sensitivity among influenza diagnostic tests, increasing healthcare cost restrains the influenza diagnostics market. Furthermore, technological advancement in the diagnosis of influenza provides opportunities to the global influenza diagnostics market. Many companies are struggling to implement modern technologies to diagnose influenza to achieve quick and reliable outcomes while being cost-efficient. Rapid molecular assays and RT-PCR are one of these developments. These advances increase the speed of the tests and number of diagnoses; hence, it gives the future influenza diagnostics market growth.

Impact of COVID-19 on the global influenza diagnostics market:

The symptoms of Influenza A or B are as same as the COVID-19, and pneumonia caused by IAVs shows symptoms like coronavirus. Both coronavirus and influenza are respiratory diseases and cause mild to severe diseases and also death. Hence, only diagnostic tests can differentiate SARS-CoV-2 and flu infection diseases and distinguish SARS-CoV-2 and influenza infection. When Coronavirus and influenza viruses are cocirculating, the medical professionals recommend influenza diagnostics. As a result, with this ongoing pandemic, the influenza diagnostic market increases intensely.

Amid COVID-19 Multiplex Assay, a real-time reverse-transcription polymerase chain reaction (RT-PCR) test identifies and differentiates RNA from SARS-CoV-2, influenza A virus, and influenza B virus in upper or lower respiratory specimens was given Emergency Use Authorization by the USFDA. Besides, when influenza season collides with the covid – 19 pandemics, the Centers for Disease Control and Prevention (CDC) recommends the co-testing for COVID-19 and influenza.  But due to travel bans, it becomes difficult to diagnose influenza in some cases, such as when the specimen is transported to the lab. Besides, the diagnosis is made in close contact; hence, there is a high chance of infections.

REPORT COVERAGE:

REPORT METRIC

DETAILS

Market Size Available

2020 to 2026

Base Year

2020

Forecast Period

2021 to 2026

Segments Covered

By Test Type, Type of Flu, End-User, and Region

Various Analyses Covered

Global, Regional & Country Level Analysis, Segment-Level Analysis, Drivers, Restraints, Opportunities, Challenges, PESTLE Analysis, Porter’s Five Forces Analysis, Competitive Landscape, Analyst Overview on Investment Opportunities, COVID-19 Impact

Regions Covered

North America, Europe, Asia Pacific, Latin America, Middle East & Africa

 

This research report on the global influenza diagnostics market has been segmented and sub-segmented based on the test type, type of flu, end-user, and region.

Influenza Diagnostics Market – By Test Type:

  • Molecular Diagnostic Tests
    • RT-PCR
    • LAMP
    • NASBA
  • Traditional Diagnostic Tests
    • Rapid Influenza Detection Tests
    • Serological assays
    • Direct Fluorescent Antibody
    • Viral Culture
    • H1N1 Influenza A Virus Identification Kits
    • Immunoassay Kits
    • Immunofluorescence Antibody Assay

The rapid influenza detection tests segment is expected to be the most significant market share during the forecast period based on the test type. Rapid influenza diagnostic tests are immunoassays that identify influenza A and B viral nucleoprotein antigens in respiratory specimens. Results of the tests are displayed in a qualitative way, such as positive and negative. The RIDT tests are the standard gold test employed to diagnose influenza because of their quick result time, less than 30 minutes. Hence the RIDT is expected to dominate the influenza diagnostic market in the coming years. 

Influenza Diagnostics Market – By Type of Flu:

  • Type A Flu
  • Type B Flu
  • Type C Flu

Based on the type of flu, the Type-A Flu is projected to account for the largest share between 2021 to 2026. Type A influenza infection can be severe and cause widespread outbreaks and disease. The common symptoms of type A condition can be coughing, sneezing, sore throat, fever, and headache. However, in some milder cases, the flu Can resolve on its own without significant symptoms. In contrast, instances of severe type influenza can be life-threatening.

Influenza Diagnostics Market – By End-User:

  • Hospitals
  • Diagnostic Laboratories 
  • Research and Academic Institute 
  • Contract research organization (CROs)

Based on the end-user, the segment of hospitals is forecasted to be the most dominant among all during the forecast period. Hospitals are holding the largest market share in the influenza market due to their beneficial factors such as accessibility and higher preference for this establishment. However, the market growth is expected to slow down with the advent of POCT laboratories that offer accurate results. 

Influenza Diagnostics Market – By Region:

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East and Africa

Among these regions, the North American market is expected to be the top-performing region globally during the forecast period. This region has witnessed the rising number of influenza screening tests performed, and the prevalence of influenza drives the market growth during the forecast period. In the North American regional market, the United States is predicted to lead, while Canada is expected to be another lucrative market in North America.

The European region held a substantial market share of the global influenza diagnostics market in 2020 and is estimated to register a healthy CAGR between 2021 to 2026. The vast availability of rapid diagnostic tests and a wide range of diagnostics procedures augment market growth in this region.

The Asia Pacific is one of the fastest-growing regions in the global influenza diagnostics market during the forecast period. In APAC regional market, the major contributors are China, India, and Japan. The Chinese influenza diagnostics market is expected to benefit from favorable factors such as adaptation of new technology and rising awareness among people regarding influenza. The Indian market is anticipated to contribute a significant share to the APAC regional market during the forecast period.

Middle East Africa is most likely to have a moderate share of the Influenza diagnostics market over the forecast period. The proliferation of influenza and the adoption of advanced technologies are most likely to create market growth in this region.

KEY MARKET PARTICIPANTS:

Some of the key players operating in the global influenza diagnostics market are Abbott Laboratories Inc., Hoffmann-La Roche AG, Novartis AG, Quidel Corporation, Sekisui Diagnostics, Thermo Fisher Scientific Inc., Becton, Dickinson and Company, Danaher Corporation (Cepheid), Hologic Inc., GenMark Diagnostics, SIEMENS, Luminex Corporation, Enigma Diagnostics, and several others.

These players working on various strategies such as merger, acquisition, partnership. They also seek government support to research new techniques. For Instance, On 20 January 2021, Thermo Fisher acquired point-of-care molecular diagnostics provider Mesa Biotech that has developed a PCR-based rapid point-of-care testing platform for detecting infectious diseases such as SARS-CoV-2, Influenza A and B, respiratory syncytial virus (RSV), and Strep A.

  1. Introduction                             
    1. Market Definition                  
    2. Scope of the report               
    3. Study Assumptions               
    4. Base Currency, Base Year and Forecast Periods                       
  2. Research Methodology                                       
    1. Analysis Design                      
    2. Research Phases                    
      1. Secondary Research          
      2. Primary Research 
      3. Data Modelling    
      4. Expert Validation 
    3. Study Timeline                       
  3. Report Overview                                    
    1. Executive Summary              
    2. Key Inferencees                     
  4. Market Dynamics                                   
    1. Impact Analysis                      
      1. Drivers     
      2. Restaints 
      3. Opportunities       
    2. Regulatory Environment                    
    3. Technology Timeline & Recent Trends                         
  5. Competitor Benchmarking Analysis                                
    1. Key Player Benchmarking                   
      1. Market share analysis       
      2. Products/Service  
      3. Regional Presence
    2. Mergers & Acquistion Landscape                   
    3. Joint Ventures & Collaborations                     
  6. Market Segmentation                                          
    1. Influenza Diagnostics Market, By Test Type                        
      1. Molecular Diagnostic Tests
        1. RT-PCR
        2. LAMP
        3. NASBA
      2. Traditional Diagnostic Tests
        1. Rapid Influenza Detection Tests
        2. Serological Assays
        3. Direct Fluorescent Antibody
        4. Viral Culture
        5. H1N1 Influenza A Virus Identification Kits
        6. Immunoassay Kits
        7. Immunofluorescence Antibody Assay
      3. Market Size Estimations & Forecasts (2021-2026) 
      4. Y-o-Y Growth Rate Analysis            
      5. Market Attractiveness Index          
    2. Influenza Diagnostics Market, By Type of Flu
      1. Type A Flu
      2. Type B Flu
      3. Type C Flu
      4. Market Size Estimations & Forecasts (2021-2026) 
      5. Y-o-Y Growth Rate Analysis            
      6. Market Attractiveness Index          
    3. Influenza Diagnostics Market, By End-User Industry               
      1. Hospitals
      2. Diagnostic Laboratories
      3. Research and Academic Institute
      4. Contract research organization (CROs)
      5. Market Size Estimations & Forecasts (2021-2026) 
      6. Y-o-Y Growth Rate Analysis            
      7. Market Attractiveness Index    
  7. Geographical Landscape                                     
    1. Global Identity Governance and Administration Market, by Region                            
    2. North America - Market Analysis (2018 - 2024)                        
      1. By Country            
        1. USA
        2. Canada
    3. Europe                      
      1. By Country            
        1. UK
        2. France
        3. Germany
        4. Spain
        5. Italy
        6. Rest of Europe
    4. Asia Pacific                
      1. By Country            
        1. China
        2. India
        3. Japan
        4. South Korea
        5. Southeast Asia
        6. Australia & NZ
        7. Rest of Asia-Pacific
    5. Latin America                         
      1. By Country            
        1. Brazil
        2. Argentina
        3. Mexico
        4. Rest of Latin America
    6. Middle East and Africa                       
      1. By Country            
        1. Middle East
        2. Africa
  8. Key Player Analysis                                
    1. Abbott Laboratories Inc.                          
      1. Business Description         
      2. Products/Service  
      3. Financials
      4. SWOT Analysis     
      5. Recent Developments       
      6. Analyst Overview 
    2. Hoffmann-La Roche AG
    3. Novartis AG
    4. Quidel Corporation
    5. Sekisui Diagnostics
    6. Thermo Fisher Scientific Inc.
    7. Becton, Dickinson and Company
    8. Danaher Corporation (Cepheid)
    9. Hologic Inc.
    10. GenMark Diagnostics
    11. SIEMENS
    12. Luminex Corporation
    13. Enigma Diagnostics
  9. Market Outlook & Investment Opportunities                             
  10. Appendix                                       
      1. List of Tables    
      2. List of Figures
  • Global, regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped.
  • Segment-level analysis in terms of test type, type of flu, end-user along with market size forecasts and estimations to detect key areas of industry growth in detail.
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics.
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis.
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development.
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment.
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies.
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions.
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market.
  1. Global Influenza Diagnostics Market, By Region, From 2021-2026 ( USD Billion )
  2. Global Influenza Diagnostics Market, By Test Type, From 2021-2026 ( USD Billion )
  3. Global Molecular Diagnostic Tests Market, By Region, From 2021-2026 ( USD Billion )
  4. Global Traditional Diagnostic Tests Market, By Region, From 2021-2026 ( USD Billion )
  5. Global Influenza Diagnostics Market, By Type of Flu, From 2021-2026 ( USD Billion )
  6. Global Type A Flu Market, By Region, From 2021-2026 ( USD Billion )
  7. Global Type B Flu Market, By Region, From 2021-2026 ( USD Billion )
  8. Global Type C Flu Market, By Region, From 2021-2026 ( USD Billion )
  9. Global Influenza Diagnostics Market, By End-User, From 2021-2026 ( USD Billion )
  10. Global Hospitals Market, By Region, From 2021-2026 ( USD Billion )
  11. Global Diagnostic Laboratories Market, By Region, From 2021-2026 ( USD Billion )
  12. Global Research and Academic Institutes Market, By Region, From 2021-2026 ( USD Billion )
  13. Global Contract research organization (CROs) Market, By Region, From 2021-2026 ( USD Billion )
  14. Global Influenza Diagnostics Market, By Molecular Diagnostic Tests, From 2021-2026 (USD Million)
  15. Global RT-PCR Market, By Region, From 2021-2026 (USD Million)
  16. Global LAMP Market, By Region, From 2021-2026 (USD Million)
  17. Global NASBA Market, By Region, From 2021-2026 (USD Million)
  18. Global Influenza Diagnostics Market, By Traditional Diagnostic Tests, From 2021-2026 (USD Million)
  19. Global Rapid Influenza Detection Tests Market, By Region, From 2021-2026 (USD Million)
  20. Global Serological Assays Market, By Region, From 2021-2026 (USD Million)
  21. Global Direct Fluorescent Antibody Market, By Region, From 2021-2026 (USD Million)
  22. Global Viral Culture Market, By Region, From 2021-2026 (USD Million)
  23. Global H1N1 Influenza A Virus Identification Kits Market, By Region, From 2021-2026 (USD Million)
  24. Global Immunoassay Kits Market, By Region, From 2021-2026 (USD Million)
  25. Global Immunofluorescence Antibody Assay Market, By Region, From 2021-2026 (USD Million)
  26. North America Influenza Diagnostics Market, By Test Type, From 2021-2026 ( USD Billion )
  27. North America Molecular Diagnostic Tests Market, By Region, From 2021-2026 ( USD Billion )
  28. North America Traditional Diagnostic Tests Market, By Region, From 2021-2026 ( USD Billion )
  29. North America Influenza Diagnostics Market, By Type of Flu, From 2021-2026 ( USD Billion )
  30. North America Type A Flu Market, By Region, From 2021-2026 ( USD Billion )
  31. North America Type B Flu Market, By Region, From 2021-2026 ( USD Billion )
  32. North America Type C Flu Market, By Region, From 2021-2026 ( USD Billion )
  33. North America Influenza Diagnostics Market, By End-User, From 2021-2026 ( USD Billion )
  34. North America Hospitals Market, By Region, From 2021-2026 ( USD Billion )
  35. North America Diagnostic Laboratories Market, By Region, From 2021-2026 ( USD Billion )
  36. North America Research and Academic Institutes Market, By Region, From 2021-2026 ( USD Billion )
  37. North America Contract research organization (CROs) Market, By Region, From 2021-2026 ( USD Billion )
  38. United States Influenza Diagnostics Market, By Test Type, From 2021-2026 ( USD Billion )
  39. United States Influenza Diagnostics Market, By Type of Flu, From 2021-2026 ( USD Billion )
  40. United States Influenza Diagnostics Market, By End-User, From 2021-2026 ( USD Billion )
  41. Canada Influenza Diagnostics Market, By Test Type, From 2021-2026 ( USD Billion )
  42. Canada Influenza Diagnostics Market, By Type of Flu, From 2021-2026 ( USD Billion )
  43. Canada Influenza Diagnostics Market, By End-User, From 2021-2026 ( USD Billion )
  44. North America Influenza Diagnostics Market, By Molecular Diagnostic Tests, From 2021-2026 (USD Million)
  45. North America RT-PCR Market, By Region, From 2021-2026 (USD Million)
  46. North America LAMP Market, By Region, From 2021-2026 (USD Million)
  47. North America NASBA Market, By Region, From 2021-2026 (USD Million)
  48. United States Influenza Diagnostics Market, By Molecular Diagnostic Tests, From 2021-2026 (USD Million)
  49. Canada Influenza Diagnostics Market, By Molecular Diagnostic Tests, From 2021-2026 (USD Million)
  50. North America Influenza Diagnostics Market, By Traditional Diagnostic Tests, From 2021-2026 (USD Million)
  51. North America Rapid Influenza Detection Tests Market, By Region, From 2021-2026 (USD Million)
  52. North America Serological Assays Market, By Region, From 2021-2026 (USD Million)
  53. North America Direct Fluorescent Antibody Market, By Region, From 2021-2026 (USD Million)
  54. North America Viral Culture Market, By Region, From 2021-2026 (USD Million)
  55. North America H1N1 Influenza A Virus Identification Kits Market, By Region, From 2021-2026 (USD Million)
  56. North America Immunoassay Kits Market, By Region, From 2021-2026 (USD Million)
  57. North America Immunofluorescence Antibody Assay Market, By Region, From 2021-2026 (USD Million)
  58. United States Influenza Diagnostics Market, By Traditional Diagnostic Tests, From 2021-2026 (USD Million)
  59. Canada Influenza Diagnostics Market, By Traditional Diagnostic Tests, From 2021-2026 (USD Million)
  60. Europe Influenza Diagnostics Market, By Test Type, From 2021-2026 ( USD Billion )
  61. Europe Molecular Diagnostic Tests Market, By Region, From 2021-2026 ( USD Billion )
  62. Europe Traditional Diagnostic Tests Market, By Region, From 2021-2026 ( USD Billion )
  63. Europe Influenza Diagnostics Market, By Type of Flu, From 2021-2026 ( USD Billion )
  64. Europe Type A Flu Market, By Region, From 2021-2026 ( USD Billion )
  65. Europe Type B Flu Market, By Region, From 2021-2026 ( USD Billion )
  66. Europe Type C Flu Market, By Region, From 2021-2026 ( USD Billion )
  67. Europe Influenza Diagnostics Market, By End-User, From 2021-2026 ( USD Billion )
  68. Europe Hospitals Market, By Region, From 2021-2026 ( USD Billion )
  69. Europe Diagnostic Laboratories Market, By Region, From 2021-2026 ( USD Billion )
  70. Europe Research and Academic Institutes Market, By Region, From 2021-2026 ( USD Billion )
  71. Europe Contract research organization (CROs) Market, By Region, From 2021-2026 ( USD Billion )
  72. U.K. Influenza Diagnostics Market, By Test Type, From 2021-2026 ( USD Billion )
  73. U.K. Influenza Diagnostics Market, By Type of Flu, From 2021-2026 ( USD Billion )
  74. U.K. Influenza Diagnostics Market, By End-User, From 2021-2026 ( USD Billion )
  75. Germany Influenza Diagnostics Market, By Test Type, From 2021-2026 ( USD Billion )
  76. Germany Influenza Diagnostics Market, By Type of Flu, From 2021-2026 ( USD Billion )
  77. Germany Influenza Diagnostics Market, By End-User, From 2021-2026 ( USD Billion )
  78. France Influenza Diagnostics Market, By Test Type, From 2021-2026 ( USD Billion )
  79. France Influenza Diagnostics Market, By Type of Flu, From 2021-2026 ( USD Billion )
  80. France Influenza Diagnostics Market, By End-User, From 2021-2026 ( USD Billion )
  81. Italy Influenza Diagnostics Market, By Test Type, From 2021-2026 ( USD Billion )
  82. Italy Influenza Diagnostics Market, By Type of Flu, From 2021-2026 ( USD Billion )
  83. Italy Influenza Diagnostics Market, By End-User, From 2021-2026 ( USD Billion )
  84. Spain Influenza Diagnostics Market, By Test Type, From 2021-2026 ( USD Billion )
  85. Spain Influenza Diagnostics Market, By Type of Flu, From 2021-2026 ( USD Billion )
  86. Spain Influenza Diagnostics Market, By End-User, From 2021-2026 ( USD Billion )
  87. Europe Influenza Diagnostics Market, By Molecular Diagnostic Tests, From 2021-2026 (USD Million)
  88. Europe RT-PCR Market, By Region, From 2021-2026 (USD Million)
  89. Europe LAMP Market, By Region, From 2021-2026 (USD Million)
  90. Europe NASBA Market, By Region, From 2021-2026 (USD Million)
  91. U.K. Influenza Diagnostics Market, By Molecular Diagnostic Tests, From 2021-2026 (USD Million)
  92. Germany Influenza Diagnostics Market, By Molecular Diagnostic Tests, From 2021-2026 (USD Million)
  93. France Influenza Diagnostics Market, By Molecular Diagnostic Tests, From 2021-2026 (USD Million)
  94. Italy Influenza Diagnostics Market, By Molecular Diagnostic Tests, From 2021-2026 (USD Million)
  95. Spain Influenza Diagnostics Market, By Molecular Diagnostic Tests, From 2021-2026 (USD Million)
  96. Europe Influenza Diagnostics Market, By Traditional Diagnostic Tests, From 2021-2026 (USD Million)
  97. Europe Rapid Influenza Detection Tests Market, By Region, From 2021-2026 (USD Million)
  98. Europe Serological Assays Market, By Region, From 2021-2026 (USD Million)
  99. Europe Direct Fluorescent Antibody Market, By Region, From 2021-2026 (USD Million)
  100. Europe Viral Culture Market, By Region, From 2021-2026 (USD Million)
  101. Europe H1N1 Influenza A Virus Identification Kits Market, By Region, From 2021-2026 (USD Million)
  102. Europe Immunoassay Kits Market, By Region, From 2021-2026 (USD Million)
  103. Europe Immunofluorescence Antibody Assay Market, By Region, From 2021-2026 (USD Million)
  104. U.K. Influenza Diagnostics Market, By Traditional Diagnostic Tests, From 2021-2026 (USD Million)
  105. Germany Influenza Diagnostics Market, By Traditional Diagnostic Tests, From 2021-2026 (USD Million)
  106. France Influenza Diagnostics Market, By Traditional Diagnostic Tests, From 2021-2026 (USD Million)
  107. Italy Influenza Diagnostics Market, By Traditional Diagnostic Tests, From 2021-2026 (USD Million)
  108. Spain Influenza Diagnostics Market, By Traditional Diagnostic Tests, From 2021-2026 (USD Million)
  109. Asia Pacific Influenza Diagnostics Market, By Test Type, From 2021-2026 ( USD Billion )
  110. Asia Pacific Molecular Diagnostic Tests Market, By Region, From 2021-2026 ( USD Billion )
  111. Asia Pacific Traditional Diagnostic Tests Market, By Region, From 2021-2026 ( USD Billion )
  112. Asia Pacific Influenza Diagnostics Market, By Type of Flu, From 2021-2026 ( USD Billion )
  113. Asia Pacific Type A Flu Market, By Region, From 2021-2026 ( USD Billion )
  114. Asia Pacific Type B Flu Market, By Region, From 2021-2026 ( USD Billion )
  115. Asia Pacific Type C Flu Market, By Region, From 2021-2026 ( USD Billion )
  116. Asia Pacific Influenza Diagnostics Market, By End-User, From 2021-2026 ( USD Billion )
  117. Asia Pacific Hospitals Market, By Region, From 2021-2026 ( USD Billion )
  118. Asia Pacific Diagnostic Laboratories Market, By Region, From 2021-2026 ( USD Billion )
  119. Asia Pacific Research and Academic Institute  Market, By Region, From 2021-2026 ( USD Billion )
  120. Asia Pacific Contract research organization (CROs) Market, By Region, From 2021-2026 ( USD Billion )
  121. Japan Influenza Diagnostics Market, By Test Type, From 2021-2026 ( USD Billion )
  122. Japan Influenza Diagnostics Market, By Type of Flu, From 2021-2026 ( USD Billion )
  123. Japan Influenza Diagnostics Market, By End-User, From 2021-2026 ( USD Billion )
  124. China Influenza Diagnostics Market, By Test Type, From 2021-2026 ( USD Billion )
  125. China Influenza Diagnostics Market, By Type of Flu, From 2021-2026 ( USD Billion )
  126. China Influenza Diagnostics Market, By End-User, From 2021-2026 ( USD Billion )
  127. India Influenza Diagnostics Market, By Test Type, From 2021-2026 ( USD Billion )
  128. India Influenza Diagnostics Market, By Type of Flu, From 2021-2026 ( USD Billion )
  129. India Influenza Diagnostics Market, By End-User, From 2021-2026 ( USD Billion )
  130. Australia Influenza Diagnostics Market, By Test Type, From 2021-2026 ( USD Billion )
  131. Australia Influenza Diagnostics Market, By Type of Flu, From 2021-2026 ( USD Billion )
  132. Australia Influenza Diagnostics Market, By End-User, From 2021-2026 ( USD Billion )
  133. South Korea Influenza Diagnostics Market, By Test Type, From 2021-2026 ( USD Billion )
  134. South Korea Influenza Diagnostics Market, By Type of Flu, From 2021-2026 ( USD Billion )
  135. South Korea Influenza Diagnostics Market, By End-User, From 2021-2026 ( USD Billion )
  136. Asia Pacific Influenza Diagnostics Market, By Molecular Diagnostic Tests, From 2021-2026 (USD Million)
  137. Asia Pacific RT-PCR Market, By Region, From 2021-2026 (USD Million)
  138. Asia Pacific LAMP Market, By Region, From 2021-2026 (USD Million)
  139. Asia Pacific NASBA Market, By Region, From 2021-2026 (USD Million)
  140. Japan Influenza Diagnostics Market, By Molecular Diagnostic Tests, From 2021-2026 (USD Million)
  141. China Influenza Diagnostics Market, By Molecular Diagnostic Tests, From 2021-2026 (USD Million)
  142. India Influenza Diagnostics Market, By Molecular Diagnostic Tests, From 2021-2026 (USD Million)
  143. Australia Influenza Diagnostics Market, By Molecular Diagnostic Tests, From 2021-2026 (USD Million)
  144. Asia Pacific Influenza Diagnostics Market, By Traditional Diagnostic Tests, From 2021-2026 (USD Million)
  145. Asia Pacific Rapid Influenza Detection Tests Market, By Region, From 2021-2026 (USD Million)
  146. Asia Pacific Serological Assays Market, By Region, From 2021-2026 (USD Million)
  147. Asia Pacific Direct Fluorescent Antibody Market, By Region, From 2021-2026 (USD Million)
  148. Asia Pacific Viral Culture Market, By Region, From 2021-2026 (USD Million)
  149. Asia Pacific H1N1 Influenza A Virus Identification Kits Market, By Region, From 2021-2026 (USD Million)
  150. Asia Pacific Immunoassay Kits Market, By Region, From 2021-2026 (USD Million)
  151. Asia Pacific Immunofluorescence Antibody Assay Market, By Region, From 2021-2026 (USD Million)
  152. Japan Influenza Diagnostics Market, By Traditional Diagnostic Tests, From 2021-2026 (USD Million)
  153. China Influenza Diagnostics Market, By Traditional Diagnostic Tests, From 2021-2026 (USD Million)
  154. India Influenza Diagnostics Market, By Traditional Diagnostic Tests, From 2021-2026 (USD Million)
  155. Australia Influenza Diagnostics Market, By Traditional Diagnostic Tests, From 2021-2026 (USD Million)
  156. Latin America Influenza Diagnostics Market, By Test Type, From 2021-2026 ( USD Billion )
  157. Latin America Molecular Diagnostic Tests Market, By Region, From 2021-2026 ( USD Billion )
  158. Latin America Traditional Diagnostic Tests Market, By Region, From 2021-2026 ( USD Billion )
  159. Latin America Influenza Diagnostics Market, By Type of Flu, From 2021-2026 ( USD Billion )
  160. Latin America Type A Flu Market, By Region, From 2021-2026 ( USD Billion )
  161. Latin America Type B Flu Market, By Region, From 2021-2026 ( USD Billion )
  162. Latin America Type C Flu Market, By Region, From 2021-2026 ( USD Billion )
  163. Latin America Influenza Diagnostics Market, By End-User, From 2021-2026 ( USD Billion )
  164. Latin America Hospitals Market, By Region, From 2021-2026 ( USD Billion )
  165. Latin America Diagnostic Laboratories Market, By Region, From 2021-2026 ( USD Billion )
  166. Latin America Research and Academic Institutes Market, By Region, From 2021-2026 ( USD Billion )
  167. Latin America Contract research organization (CROs) Market, By Region, From 2021-2026 ( USD Billion )
  168. Brazil Influenza Diagnostics Market, By Test Type, From 2021-2026 ( USD Billion )
  169. Brazil Influenza Diagnostics Market, By Type of Flu, From 2021-2026 ( USD Billion )
  170. Brazil Influenza Diagnostics Market, By End-User, From 2021-2026 ( USD Billion )
  171. Argentina Influenza Diagnostics Market, By Test Type, From 2021-2026 ( USD Billion )
  172. Argentina Influenza Diagnostics Market, By Type of Flu, From 2021-2026 ( USD Billion )
  173. Argentina Influenza Diagnostics Market, By End-User, From 2021-2026 ( USD Billion )
  174. Mexico Influenza Diagnostics Market, By Test Type, From 2021-2026 ( USD Billion )
  175. Mexico Influenza Diagnostics Market, By Type of Flu, From 2021-2026 ( USD Billion )
  176. Mexico Influenza Diagnostics Market, By End-User, From 2021-2026 ( USD Billion )
  177. Rest of Latin America Influenza Diagnostics Market, By Test Type, From 2021-2026 ( USD Billion )
  178. Rest of Latin America Influenza Diagnostics Market, By Type of Flu, From 2021-2026 ( USD Billion )
  179. Rest of Latin America Influenza Diagnostics Market, By End-User, From 2021-2026 ( USD Billion )
  180. Latin America Influenza Diagnostics Market, By Molecular Diagnostic Tests, From 2021-2026 (USD Million)
  181. Latin America RT-PCR Market, By Region, From 2021-2026 (USD Million)
  182. Latin America LAMP Market, By Region, From 2021-2026 (USD Million)
  183. Latin America NASBA Market, By Region, From 2021-2026 (USD Million)
  184. Brazil Influenza Diagnostics Market, By Molecular Diagnostic Tests, From 2021-2026 (USD Million)
  185. Argentina Influenza Diagnostics Market, By Molecular Diagnostic Tests, From 2021-2026 (USD Million)
  186. Mexico Influenza Diagnostics Market, By Molecular Diagnostic Tests, From 2021-2026 (USD Million)
  187. Latin America Influenza Diagnostics Market, By Traditional Diagnostic Tests, From 2021-2026 (USD Million)
  188. Latin America Rapid Influenza Detection Tests Market, By Region, From 2021-2026 (USD Million)
  189. Latin America Serological Assays Market, By Region, From 2021-2026 (USD Million)
  190. Latin America Direct Fluorescent Antibody Market, By Region, From 2021-2026 (USD Million)
  191. Latin America Viral Culture Market, By Region, From 2021-2026 (USD Million)
  192. Latin America H1N1 Influenza A Virus Identification Kits Market, By Region, From 2021-2026 (USD Million)
  193. Latin America Immunoassay Kits Market, By Region, From 2021-2026 (USD Million)
  194. Latin America Immunofluorescence Antibody Assay Market, By Region, From 2021-2026 (USD Million)
  195. Brazil Influenza Diagnostics Market, By Traditional Diagnostic Tests, From 2021-2026 (USD Million)
  196. Argentina Influenza Diagnostics Market, By Traditional Diagnostic Tests, From 2021-2026 (USD Million)
  197. Mexico Influenza Diagnostics Market, By Traditional Diagnostic Tests, From 2021-2026 (USD Million)
  198. The Middle East and Africa Influenza Diagnostics Market, By Test Type, From 2021-2026 ( USD Billion )
  199. The Middle East and Africa Molecular Diagnostic Tests Market, By Region, From 2021-2026 ( USD Billion )
  200. The Middle East and Africa Traditional Diagnostic Tests Market, By Region, From 2021-2026 ( USD Billion )
  201. The Middle East and Africa Influenza Diagnostics Market, By Type of Flu, From 2021-2026 ( USD Billion )
  202. The Middle East and Africa Type A Flu Market, By Region, From 2021-2026 ( USD Billion )
  203. The Middle East and Africa Type B Flu Market, By Region, From 2021-2026 ( USD Billion )
  204. The Middle East and Africa Type C Flu Market, By Region, From 2021-2026 ( USD Billion )
  205. The Middle East and Africa Influenza Diagnostics Market, By End-User, From 2021-2026 ( USD Billion )
  206. The Middle East and Africa Hospitals Market, By Region, From 2021-2026 ( USD Billion )
  207. The Middle East and Africa Diagnostic Laboratories Market, By Region, From 2021-2026 ( USD Billion )
  208. The Middle East and Africa Research and Academic Institutes Market, By Region, From 2021-2026 ( USD Billion )
  209. The Middle East and Africa Contract research organization (CROs) Market, By Region, From 2021-2026 ( USD Billion )
  210. Middle East Influenza Diagnostics Market, By Test Type, From 2021-2026 ( USD Billion )
  211. Middle East Influenza Diagnostics Market, By Type of Flu, From 2021-2026 ( USD Billion )
  212. Middle East Influenza Diagnostics Market, By End-User, From 2021-2026 ( USD Billion )
  213. Africa Influenza Diagnostics Market, By Test Type, From 2021-2026 ( USD Billion )
  214. Africa Influenza Diagnostics Market, By Type of Flu, From 2021-2026 ( USD Billion )
  215. Africa Influenza Diagnostics Market, By End-User, From 2021-2026 ( USD Billion )
  216. The Middle East and Africa Influenza Diagnostics Market, By Molecular Diagnostic Tests, From 2021-2026 (USD Million)
  217. The Middle East and Africa RT-PCR Market, By Region, From 2021-2026 (USD Million)
  218. The Middle East and Africa LAMP Market, By Region, From 2021-2026 (USD Million)
  219. The Middle East and Africa NASBA Market, By Region, From 2021-2026 (USD Million)
  220. Middle East Influenza Diagnostics Market, By Molecular Diagnostic Tests, From 2021-2026 (USD Million)
  221. Africa Influenza Diagnostics Market, By Molecular Diagnostic Tests, From 2021-2026 (USD Million)
  222. The Middle East and Africa Influenza Diagnostics Market, By Traditional Diagnostic Tests, From 2021-2026 (USD Million)
  223. The Middle East and Africa Rapid Influenza Detection Tests Market, By Region, From 2021-2026 (USD Million)
  224. The Middle East and Africa Serological Assays Market, By Region, From 2021-2026 (USD Million)
  225. The Middle East and Africa Direct Fluorescent Antibody Market, By Region, From 2021-2026 (USD Million)
  226. The Middle East and Africa Viral Culture Market, By Region, From 2021-2026 (USD Million)
  227. The Middle East and Africa H1N1 Influenza A Virus Identification Kits Market, By Region, From 2021-2026 (USD Million)
  228. The Middle East and Africa Immunoassay Kits Market, By Region, From 2021-2026 (USD Million)
  229. The Middle East and Africa Immunofluorescence Antibody Assay Market, By Region, From 2021-2026 (USD Million)
  230. Middle East Influenza Diagnostics Market, By Traditional Diagnostic Tests, From 2021-2026 (USD Million)
  231. Africa Influenza Diagnostics Market, By Traditional Diagnostic Tests, From 2021-2026 (USD Million)

Please wait. . . . Your request is being processed

Related Reports

LICENCE TYPE

$ 1234 4255

Clients
clients
clients
clients
clients
clients
clients
Click for Request Sample